Skip to Content

Mitomycin Pregnancy and Breastfeeding Warnings

Mitomycin is also known as: Mutamycin

Mitomycin Pregnancy Warnings

Mitomycin has not been formally assigned to a pregnancy category by the FDA. Animal studies have revealed evidence of teratogenicity. There are no controlled data in human pregnancy. The effect of mitomycin on fertility has not been reported. The safe use of mitomycin in pregnant women has not been established.

See references

Mitomycin Breastfeeding Warnings

There are no data on the excretion of mitomycin into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Mutamycin (mitomycin)." Bristol-Myers Squibb, Princeton, NJ.

References for breastfeeding information

  1. "Product Information. Mutamycin (mitomycin)." Bristol-Myers Squibb, Princeton, NJ.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide